NDC 0093-8210 Finzala
Norethindrone Acetate And Ethinyl Estradiol And Ferrous Fumarate Kit

Product Information

What is NDC 0093-8210?

The NDC code 0093-8210 is assigned by the FDA to the product Finzala which is a human prescription drug product labeled by Teva Pharmaceuticals Usa, Inc.. The generic name of Finzala is norethindrone acetate and ethinyl estradiol and ferrous fumarate. The product's dosage form is kit and is administered via form. The product is distributed in a single package with assigned NDC code 0093-8210-62 3 pouch in 1 carton / 1 blister pack in 1 pouch (0093-8210-28) / 1 kit in 1 blister pack * 24 tablet, chewable in 1 blister pack (0093-3476-38) * 4 tablet in 1 blister pack (0093-3525-44). This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information, RxNorm crosswalk and the complete product label.

NDC Product Code0093-8210
Proprietary Name What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Finzala
Non-Proprietary Name What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
Norethindrone Acetate And Ethinyl Estradiol And Ferrous Fumarate
Product Type What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
Human Prescription Drug
Dosage FormKit - A packaged collection of related material.
Product Labeler Information What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.
Teva Pharmaceuticals Usa, Inc.
Labeler Code0093
FDA Application Number What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
ANDA210087
Marketing Category What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.
08-04-2022
Listing Expiration Date What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.
12-31-2023
Exclude Flag What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".
N
NDC Code Structure

What are the uses for Finzala?


Product Characteristics

Color(s)WHITE (C48325)
BROWN (C48332)
ShapeROUND (C48348)
Size(s)6 MM
Imprint(s)E24;TV
F75;TV
Score1
Flavor(s)SPEARMINT (C73416)

Product Packages

NDC Code 0093-8210-62

Package Description: 3 POUCH in 1 CARTON / 1 BLISTER PACK in 1 POUCH (0093-8210-28) / 1 KIT in 1 BLISTER PACK * 24 TABLET, CHEWABLE in 1 BLISTER PACK (0093-3476-38) * 4 TABLET in 1 BLISTER PACK (0093-3525-44)

Price per Unit: $0.19684 per EA

Product Details

Finzala Active Ingredients UNII Codes

NDC to RxNorm Crosswalk

What is RxNorm? RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 1426288 - norethindrone acetate 1 MG / ethinyl estradiol 20 MCG Chewable Tablet
  • RxCUI: 1426288 - ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Chewable Tablet
  • RxCUI: 1426288 - ethinyl estradiol 20 MCG / norethindrone acetate 1 MG Chewable Tablet
  • RxCUI: 1426600 - {24 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Chewable Tablet) / 4 (ferrous fumarate 75 MG Oral Tablet) } Pack
  • RxCUI: 1426600 - Eth estra-Noreth Ac 0.02-1 MG (24) Chewable Tablet / Ferr fum 75 MG (4) Oral Tablet 28 Day Pack

Finzala Inactive Ingredients UNII Codes

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.

* Please review the disclaimer below.

Finzala Product Label

FDA filings in the form of structured product labels are documents that include all published material associated whith this product. Product label information includes data like indications and usage generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Product Label Table of Contents



* Please review the disclaimer below.